Regulatory Affairs Services Provider in Oman
Oman continues to position itself as a stable and quality-focused pharmaceutical market within the GCC. Its centralized healthcare system and strict regulatory oversight create a controlled environment for market entry. While the opportunity is clear, approval in Oman depends on precise documentation, pricing alignment, and adherence to Ministry of Health requirements.
DDReg provides specialized Regulatory Affairs Services in Oman, supporting pharmaceutical companies with structured market entry, compliant submissions, and end-to-end regulatory execution.
Regulatory Authority in Oman
Pharmaceutical regulation in Oman is governed by the Directorate General of Pharmaceutical Affairs and Drug Control (DGPA) under the Ministry of Health.
The authority is responsible for product registration, pricing control, import and distribution oversight, and post-market surveillance. Oman follows a centralized approval system, where a single authorization enables market access across the country, with strict regulatory control over compliance and pricing.
Regulatory Affairs Services in Oman
DDReg delivers comprehensive Pharmaceutical Regulatory Affairs in Oman, designed to support efficient approvals and long-term compliance.
Our services include:
- Regulatory strategy and market entry planning
- Product registration support in Oman
- CTD/eCTD dossier preparation and publishing
- Dossier gap analysis and compliance review
- Submission management and coordination with DGPA
- Regulatory query handling and response support
- Pricing alignment strategy based on GCC requirements
- Coordination with local authorized representatives
- Lifecycle management including variations and renewals
- Labeling and artwork compliance support
- Regulatory intelligence and ongoing compliance monitoring
Our focus remains on submission readiness, regulatory accuracy, and execution efficiency.
Regulatory Affairs Process in Oman
Market access in Oman requires approval from the Ministry of Health prior to commercialization. Applications are submitted in CTD/eCTD format and reviewed by DGPA as part of a centralized process.
Pricing evaluation is integrated within the approval pathway, and regulatory timelines are influenced by dossier completeness and alignment with local requirements. Foreign companies are required to work through a licensed local representative for submissions and regulatory coordination.
Why Choose DDReg for Regulatory Affairs Services in Oman ?
DDReg brings a structured and execution-focused approach to regulatory operations in Oman.
- Strong understanding of DGPA regulatory expectations
- Experience in GCC regulatory alignment
- Focus on complete and submission-ready dossiers
- Integrated approach to pricing and regulatory strategy
- End-to-end support from registration to lifecycle management
This ensures consistent progress from submission to approval.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Oman portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
